Abstract:Multifunctional ICG‐SB@Lip‐ZA nanosystem focuses on remodeling the inflammatory immunosuppressive microenvironment after photothermal therapy by depleting tumor‐associated macrophages (predominantly M2‐like phenotype) using zoledronic acid as well as inhibiting cancer‐associated fibroblast activation (breaking down the barrier of immunosuppression) using SB‐505124, in order to potentiate photothermal‐immunotherapy of cancer, to block residual tumor recurrence and to increase the rate of tumor cure after PTT. Achieving full eradication of residual tumors post photothermal therapy (PTT) hinges on the immune system's activation and response. Nevertheless, the resultant local inflammation attracts a significant influx of aberrant immune cells and fibroblasts, such as tumor‐associated macrophages (TAMs) and cancer‐associated fibroblasts (CAFs), following tumor PTT. This phenomenon exacerbates immune evasion and the persistence of residual tumor cells, culminating in tumor recurrence and advancement. To tackle this challenge, a combined therapeutic approach utilizing multifunctional ICG‐SB@Lip‐ZA nanosystem has been introduced. Indocyanine green (ICG) as a photothermal‐transducer ablated tumor cells, zoledronic acid (ZA) depletes TAMs recruited by the inflammatory tumor microenvironment (mostly M2‐like phenotype), SB‐505124 affects CAFs proliferation in the tumor microenvironment (TME) by inhibiting the transforming growth factor‐β (TGF‐β) pathway, thereby removing physical barriers to T cell infiltration. In a breast cancer model, these immunomodulatory nanoliposomes markedly decrease the population of M2‐like TAMs in the TME, eliminate physical barriers hindering T cell infiltration, reshape the inflammatory immune‐suppressive tumor microenvironment, eventually leading to a rate of tumor eradication of 94%. This multifunctional ICG‐SB@Lip‐ZA nanosystem (including photothermal conversion, TAM depletion, and TGF‐β pathway blockade) offers a promising strategy for mitigating the deteriorating tumor microenvironment following PTT and presents a more efficient approach for clinical photothermal‐immune combination therapy.

Combined Photothermal Therapy and Immunotherapy: Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy (Adv. Sci. 5/2018)

Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity

An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy

Enhanced immunotherapy based on the synergistic click reaction-mediated chemotherapy and photothermal therapy for efficient tumor inhibition

A Dual Functional Drug Delivery System That Combines Photothermal Therapy and Immunotherapy to Treat Tumors.

Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers

The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumors

Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal-Immunotherapy

Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death

Multifunctional ICG‐SB@Lip‐ZA Nanosystem Focuses on Remodeling the Inflammatory‐Immunosuppressive Microenvironment After Photothermal Therapy to Potentiate Cancer Photothermal Immunotherapy

GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor

The synergistic strategies for the immuno‐oncotherapy with photothermal nanoagents

Enhancing tumor immunotherapy via photodynamic therapy with a cascade reaction of reactive oxygen species and sustaining nutrient supply

NIR-II Fluorescence and PA Imaging Guided Activation of STING Pathway in Photothermal Therapy for Boosting Cancer Immunotherapy by Theranostic Thermosensitive Liposomes

Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy Through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief

Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage

Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view

Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation

Tailoring Aggregation Extent of Photosensitizers to Boost Phototherapy Potency for Eliciting Systemic Antitumor Immunity

Photoimmunotherapy-Induced Pyroptosis Remodels the Microenvironment to Enhance Cancer Immunotherapy